Aberrant recombination and repair during immunoglobulin class switching in BRCA1-deficient human B cells

Proceedings of the National Academy of Sciences of the United States of America

Volumn 112, Issue 7, 2015, Pages 2157-2162

  Björkman, Andrea ^a   Qvist, Per ^b,c   Du, Likun ^a   Bartish, Margarita ^a   Zaravinos, Apostolos ^a   Georgiou, Konstantinos ^a   Børglum, Anders D ^b,c   Gatti, Richard A ^d,e   Törngren, Therese ^f   Pan Hammarström, Qiang ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Department of Biomedicine ^*  (Denmark)

^c AARHUS UNIVERSITY   (Denmark)

^d Laboratory Medicine   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE STRANDED DNA; BRCA1 PROTEIN; BRCA1 PROTEIN, HUMAN;

ADULT; ALTERNATIVE END JOINING; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA END JOINING REPAIR; DNA REPAIR; FANCONI ANEMIA GROUP J PROTEIN GENE; GENE DELETION; GENE FREQUENCY; GENE FUNCTION; GENE INTERACTION; GENE REARRANGEMENT; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; INDEL MUTATION; INVERTED REPEAT; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RBBP8 GENE; RECOMBINATION REPAIR; RNF168 GENE; SEQUENCE HOMOLOGY; TUMOR SUPPRESSOR GENE; GENETIC RECOMBINATION; GENETICS; METABOLISM;

B-LYMPHOCYTES; BRCA1 PROTEIN; DNA REPAIR; HUMANS; IMMUNOGLOBULIN CLASS SWITCHING; RECOMBINATION, GENETIC;

EID: 84923166583     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1418947112     Document Type: Article

References (56)

1. Lieber MR (2010) The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway. Annu Rev Biochem 79:181-211.
2. Stavnezer J, Björkman A, Du L, Cagigi A, Pan-Hammarström Q (2010) Mapping of switch recombination junctions, a tool for studying DNA repair pathways during immunoglobulin class switching. Adv Immunol 108:45-109.
3. Kotnis A, Du L, Liu C, Popov SW, Pan-Hammarström Q (2009) Non-homologous end joining in class switch recombination: The beginning of the end. Philos Trans R Soc Lond B Biol Sci 364(1517):653-665.
4. Muramatsu M, et al. (2000) Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102(5):553-563.
5. Chahwan R, Edelmann W, Scharff MD, Roa S (2012) AIDing antibody diversity by error-prone mismatch repair. Semin Immunol 24(4):293-300.
6. Daniel JA, Nussenzweig A (2013) The AID-induced DNA damage response in chromatin. Mol Cell 50(3):309-321.
7. Miki Y, et al. (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266(5182):66-71.
8. Huen MS, Sy SM, Chen J (2010) BRCA1 and its toolbox for the maintenance of genome integrity. Nat Rev Mol Cell Biol 11(2):138-148.
9. Rosen EM (2013) BRCA1 in the DNA damage response and at telomeres. Front Genet 4:85.
10. Venkitaraman AR (2014) Cancer suppression by the chromosome custodians, BRCA1 and BRCA2. Science 343(6178):1470-1475.
11. Wei L, et al. (2008) Rapid recruitment of BRCA1 to DNA double-strand breaks is dependent on its association with Ku80. Mol Cell Biol 28(24):7380-7393.
12. Jiang G, et al. (2013) BRCA1-Ku80 protein interaction enhances end-joining fidelity of chromosomal double-strand breaks in the G1 phase of the cell cycle. J Biol Chem 288(13):8966-8976.
13. Moynahan ME, Chiu JW, Koller BH, Jasin M (1999) Brca1 controls homology-directed DNA repair. Mol Cell 4(4):511-518.
14. Wang H, et al. (2001) Nonhomologous end-joining of ionizing radiation-induced DNA double-stranded breaks in human tumor cells deficient in BRCA1 or BRCA2. Cancer Res 61(1):270-277.
15. Zhong Q, Boyer TG, Chen PL, Lee WH (2002) Deficient nonhomologous end-joining activity in cell-free extracts from Brca1-null fibroblasts. Cancer Res 62(14):3966-3970.
16. Baldeyron C, et al. (2002) A single mutated BRCA1 allele leads to impaired fidelity of double strand break end-joining. Oncogene 21(9):1401-1410.
17. Thompson EG, Fares H, Dixon K (2012) BRCA1 requirement for the fidelity of plasmid DNA double-strand break repair in cultured breast epithelial cells. Environ Mol Mutagen 53(1):32-43.
18. Dohrn L, Salles D, Siehler SY, Kaufmann J, Wiesmüller L (2012) BRCA1-mediated repression of mutagenic end-joining of DNA double-strand breaks requires complex formation with BACH1. Biochem J 441(3):919-926.
19. Wang Y, et al. (2000) BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. Genes Dev 14(8):927-939.
20. Evers B, Jonkers J (2006) Mouse models of BRCA1 and BRCA2 deficiency: Past lessons, current understanding and future prospects. Oncogene 25(43):5885-5897.
21. Pan Q, et al. (2001) Regulation of switching and production of IgA in human B cells in donors with duplicated alpha1 genes. Eur J Immunol 31(12):3622-3630.
22. Pan Q, et al. (2002) Alternative end joining during switch recombination in patients with ataxia-telangiectasia. Eur J Immunol 32(5):1300-1308.
23. Du L, et al. (2008) Involvement of Artemis in nonhomologous end-joining during immunoglobulin class switch recombination. J Exp Med 205(13):3031-3040.
24. Perrin-Vidoz L, Sinilnikova OM, Stoppa-Lyonnet D, Lenoir GM, Mazoyer S (2002) The nonsense-mediated mRNA decay pathway triggers degradation of most BRCA1 mRNAs bearing premature termination codons. Hum Mol Genet 11(23):2805-2814.
25. Pan-Hammarström Q, et al. (2005) Impact of DNA ligase IV on nonhomologous end joining pathways during class switch recombination in human cells. J Exp Med 201(2): 189-194.
26. Pan Q, Rabbani H, Mills FC, Severinson E, Hammarström L (1997) Allotype-associated variation in the human gamma3 switch region as a basis for differences in IgG3 production. J Immunol 158(12):5849-5859.
27. Reina-San-Martin B, Chen J, Nussenzweig A, Nussenzweig MC (2007) Enhanced intraswitch region recombination during immunoglobulin class switch recombination in 53BP1-/- B cells. Eur J Immunol 37(1):235-239.
28. Reina-San-Martin B, et al. (2003) H2AX is required for recombination between immunoglobulin switch regions but not for intra-switch region recombination or somatic hypermutation. J Exp Med 197(12):1767-1778.
29. Boboila C, et al. (2010) Alternative end-joining catalyzes robust IgH locus deletions and translocations in the combined absence of ligase 4 and Ku70. Proc Natl Acad Sci USA 107(7):3034-3039.
30. Reina-San-Martin B, Chen HT, Nussenzweig A, Nussenzweig MC (2004) ATM is required for efficient recombination between immunoglobulin switch regions. J Exp Med 200(9):1103-1110.
31. Boboila C, Alt FW, Schwer B (2012) Classical and alternative end-joining pathways for repair of lymphocyte-specific and general DNA double-strand breaks. Adv Immunol 116:1-49.
32. Bothmer A, et al. (2013) Mechanism of DNA resection during intrachromosomal recombination and immunoglobulin class switching. J Exp Med 210(1):115-123.
33. Enervald E, et al. (2013) A regulatory role for the cohesin loader NIPBL in nonhomologous end joining during immunoglobulin class switch recombination. J Exp Med 210(12):2503-2513.
34. Xia F, et al. (2001) Deficiency of human BRCA2 leads to impaired homologous recombination but maintains normal nonhomologous end joining. Proc Natl Acad Sci USA 98(15):8644-8649.
35. Escribano-Díaz C, et al. (2013) A cell cycle-dependent regulatory circuit composed of 53BP1-RIF1 and BRCA1-CtIP controls DNA repair pathway choice. Mol Cell 49(5): 872-883.
36. Bouwman P, et al. (2010) 53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers. Nat Struct Mol Biol 17(6):688-695.
37. Bunting SF, et al. (2010) 53BP1 inhibits homologous recombination in Brca1-deficient cells by blocking resection of DNA breaks. Cell 141(2):243-254.
38. Ward IM, et al. (2004) 53BP1 is required for class switch recombination. J Cell Biol 165(4):459-464.
39. Devgan SS, et al. (2011) Homozygous deficiency of ubiquitin-ligase ring-finger protein RNF168 mimics the radiosensitivity syndrome of ataxia-telangiectasia. Cell Death Differ 18(9):1500-1506.
40. Coleman KA, Greenberg RA (2011) The BRCA1-RAP80 complex regulates DNA repair mechanism utilization by restricting end resection. J Biol Chem 286(15):13669-13680.
41. Suhasini AN, et al. (2013) Fanconi anemia group J helicase and MRE11 nuclease interact to facilitate the DNA damage response. Mol Cell Biol 33(11):2212-2227.
42. Lee-Theilen M, Matthews AJ, Kelly D, Zheng S, Chaudhuri J (2011) CtIP promotes microhomology-mediated alternative end joining during class-switch recombination. Nat Struct Mol Biol 18(1):75-79.
43. Ye Q, et al. (2001) BRCA1-induced large-scale chromatin unfolding and allele-specific effects of cancer-predisposing mutations. J Cell Biol 155(6):911-921.
44. Qvist P, et al. (2011) CtIP mutations cause Seckel and Jawad syndromes. PLoS Genet 7(10):e1002310.
45. Hasham MG, et al. (2010) Widespread genomic breaks generated by activationinduced cytidine deaminase are prevented by homologous recombination. Nat Immunol 11(9):820-826.
46. Yamane A, et al. (2013) RPA accumulation during class switch recombination represents 5′-3′ DNA-end resection during the S-G2/M phase of the cell cycle. Cell Reports 3(1):138-147.
47. Hasham MG, et al. (2012) Activation-induced cytidine deaminase-initiated off-target DNA breaks are detected and resolved during S phase. J Immunol 189(5):2374-2382.
48. Ira G, Nussenzweig A (2014) A new Riff: Rif1 eats its cake and has it too. EMBO Rep 15(6):622-624.
49. Grabarz A, et al. (2013) A role for BLM in double-strand break repair pathway choice: Prevention of CtIP/Mre11-mediated alternative nonhomologous end-joining. Cell Reports 5(1):21-28.
50. Bryant HE, et al. (2005) Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase. Nature 434(7035):913-917.
51. Zhang Y, et al. (2010) The role of mechanistic factors in promoting chromosomal translocations found in lymphoid and other cancers. Adv Immunol 106:93-133.
52. de Miranda NF, et al. (2013) DNA repair genes are selectively mutated in diffuse large B cell lymphomas. J Exp Med 210(9):1729-1742.
53. de Miranda NF, et al. (2014) Exome sequencing reveals novel mutation targets in diffuse large B-cell lymphomas derived from Chinese patients. Blood 124(16): 2544-2553.
54. Børglum AD, et al. (2001) A new locus for Seckel syndrome on chromosome 18p11.31-q11.2. Eur J Hum Genet 9(10):753-757.
55. Wagner JE, et al. (2004) Germline mutations in BRCA2: Shared genetic susceptibility to breast cancer, early onset leukemia, and Fanconi anemia. Blood 103(8):3226-3229.
56. Levran O, et al. (2005) The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia. Nat Genet 37(9):931-933.